Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy
- DOI
- 10.1002/ajh.70505
- Published
- 2026-09-23
- Container
- American Journal of Hematology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/ajh.70505,
title = {Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy},
author = {Saarang R. Deshpande and Debbie Jiang and Rebecca K. Leaf and Andrew Song and P. Connor Johnson and Caron Jacobson and Jeremy Abramson and Hanny Al‐Samkari},
year = {2026},
journal = {American Journal of Hematology},
doi = {10.1002/ajh.70505},
url = {https://doi.org/10.1002/ajh.70505}
}RIS
TY - JOUR TI - Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy AU - Saarang R. Deshpande AU - Debbie Jiang AU - Rebecca K. Leaf AU - Andrew Song AU - P. Connor Johnson AU - Caron Jacobson AU - Jeremy Abramson AU - Hanny Al‐Samkari PY - 2026 JO - American Journal of Hematology DO - 10.1002/ajh.70505 UR - https://doi.org/10.1002/ajh.70505 ER -
APA
Deshpande, S. R., Jiang, D., Leaf, R. K., Song, A., Johnson, P. C., Jacobson, C., Abramson, J., & Al‐Samkari, H. (2026). Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy. American Journal of Hematology. https://doi.org/10.1002/ajh.70505
Source records
- crossref · retrieved 2026-09-25T21:11:58.225Z